{
  "labels": {
    "done": "Done",
    "current": "Now",
    "planned": "Planned",
    "tentative": "Tentative",

    "diagnosis": "Diagnosis",
    "chemotherapy": "Chemotherapy",
    "radiotherapy": "Radiotherapy",
    "transplant": "Transplant",
    "rehab": "Rehabilitation",
    "event": "Event",
    "other": "Other"
  },
  "ui": {
    "page_title": "Medical Timeline",
    "meta_updated": "Updated",
    "legend_done": "Done — completed therapy/events",
    "legend_now": "Now — current step",
    "legend_planned": "Planned — scheduled/expected",
    "legend_tentative": "Tentative — possible, not confirmed",
    "section_completed": "Completed",
    "section_now": "Now",
    "section_plans": "Plans",
    "no_entries": "No entries yet.",
    "btn_details": "Details",
    "btn_hide": "Hide",
    "confidence": "confidence",
    "notice_tbd": "“TBD” = “to be determined”. This roadmap is informational and not medical advice."
  },
  "items": {
    "2019-01-dx-staging": {
      "when_label": "Jan–Mar 2019",
      "title": "Initial diagnosis — T‑lymphoblastic lymphoma; staging",
      "summary": "Baseline work‑up confirmed T‑lymphoblastic lymphoma; staging and baseline tests completed.",
      "details": "Hematology consultation, imaging and biopsies established the diagnosis and stage. Baseline cardiac function and labs recorded before therapy."
    },
    "2019-03-first-chemo-rt": {
      "when_label": "Mar–Aug 2019",
      "title": "Chemotherapy for T‑lymphoblastic lymphoma",
      "summary": "Systemic chemotherapy with supportive care; adjuvant radiotherapy.",
      "details": "Planned cycles with interim response assessment and end‑of‑treatment evaluation. Radiotherapy delivered as consolidation (~30 sessions)."
    },
    "2020-04-relapse-dx": {
      "when_label": "Apr 2020",
      "title": "Relapse — T‑lymphoblastic lymphoma (confirmed)",
      "summary": "Relapse confirmed; treatment plan updated.",
      "details": "Diagnostic review reconfirmed T‑LBL; systemic therapy indicated."
    },
    "2020-04-11-chemo-rt-mi": {
      "when_label": "Apr–Nov 2020",
      "title": "Chemotherapy + RT×30; severe GI bleed and myocardial infarction",
      "summary": "Chemo and radiotherapy resumed; ulcer bleeding led to MI; treatment continued after stabilization.",
      "details": "Severe anemia and tachyarrhythmia managed with transfusions and intensive care. Radiotherapy delivered in parallel with chemotherapy (~30 sessions)."
    },
    "2021-05-aggressive-leukocytosis-dx": {
      "when_label": "May 2021",
      "title": "Aggressive leukemia with extreme leukocytosis — diagnosis",
      "summary": "WBC >300k; diagnosis confirmed; cytoreduction initiated.",
      "details": "Rapid leukemic course (later Ph+ features); urgent cytoreduction and transfusion support required."
    },
    "2021-05-2023-09-chemo-aggr-leukemia": {
      "when_label": "May 2021–Sep 2023",
      "title": "Chemotherapy against aggressive leukemia",
      "summary": "Prolonged systemic therapy to reach CAR‑T eligibility and control disease.",
      "details": "Escalating/adaptive regimens targeted WBC reduction below CAR‑T threshold; intercurrent infections managed along the way."
    },
    "2022-03-26-neuro-shock": {
      "when_label": "Mar–Apr 2022",
      "title": "Systemic shock with paralysis and amnesia",
      "summary": "Resuscitation required; neurologic deficits followed by gradual recovery.",
      "details": "Acute collapse required resuscitation. Afterwards: paralysis, motor aphasia/amnesia, slowed cognition; stepwise recovery under neurology follow‑up."
    },
    "2022-10-invasive-fungal-sepsis": {
      "when_label": "Oct 2022",
      "title": "Invasive fungal infection with sepsis",
      "summary": "Severe oropharyngeal focus with systemic involvement; successfully treated.",
      "details": "Inpatient antimicrobial therapy; concomitant arrhythmias and 2022 micro‑stroke‑like symptoms noted."
    },
    "2022-12-covid-icu-gi-bleed": {
      "when_label": "Dec 2022–Jan 2023",
      "title": "COVID‑19 pneumonia (ICU, intubation) and GI bleeding; recovery",
      "summary": "Critical course with intubation and coma; bleeding and immunosuppression; subsequent stabilization.",
      "details": "Rapid deterioration of pneumonia on immunosuppression → ICU, intubation and coma; post‑ICU rehabilitation with gradual stabilization."
    },
    "2023-06-respiratory-arrest-sepsis": {
      "when_label": "Jun–Sep 2023",
      "title": "Respiratory arrest (resuscitated) and bacteremia; intensified chemotherapy",
      "summary": "Event controlled; rare bacteremia treated; chemo intensified to reach CAR‑T threshold.",
      "details": "Therapy escalated to lower WBC below CAR‑T threshold; intercurrent infections treated as detected."
    },
    "2023-10-car-t": {
      "when_label": "Oct–Nov 2023",
      "title": "CAR‑T therapy",
      "summary": "CAR‑T performed; severe toxicity (fever, neuro‑ and cardiac events) managed.",
      "details": "High fever, vomiting, transient leg paralysis… Findings consistent with neurotoxicity; gradual recovery afterwards."
    },
    "2024-01-allo-sct-brother-bradonor": {
      "when_label": "Jan 2024",
      "title": "Allogeneic stem cell infusion — sibling donor",
      "summary": "Allogeneic stem cells infused as consolidation post CAR‑T.",
      "details": "Engraftment phase under strict infection control; then ambulatory recovery."
    },
    "2024-07-abdominal-mass-hl": {
      "when_label": "Jul 2024",
      "title": "Large abdominal mass; aggressive Hodgkin lymphoma",
      "summary": "New HL distinct from prior disease; treatment strategy revised.",
      "details": "Considered possibly related to prior therapies… Oncology proposed a new chemo strategy."
    },
    "2024-08-2025-06-chemo-rt": {
      "when_label": "Aug 2024–Jun 2025",
      "title": "Escalated chemotherapy → sepsis → switch to effective regimen; RT×30",
      "summary": "Initial high dose caused sepsis; switched to a better‑tolerated effective regimen; added radiotherapy (30 sessions).",
      "details": "After septic episode, regimen adjusted for tolerability and effect. Radiotherapy added for consolidation (30 daily sessions)."
    },
    "2025-06-relapse-Ph-pos": {
      "when_label": "Late Jun 2025",
      "title": "Rising leukocytes; Ph+ lymphoid cells",
      "summary": "WBC rose from ~35k to ~67k in days; Ph+ lymphoid lineage identified.",
      "details": "Oncology proposed oral chemotherapy followed by TKI (ponatinib) after stabilization."
    },
    "2025-07-oral-chemo-14": {
      "when_label": "Jul 2025 – Now",
      "title": "Oral multi‑agent chemotherapy (14 doses)",
      "summary": "Structured per‑oral regimen at home, total of 14 doses.",
      "details": "Complex oral combination with interim laboratory and tolerance monitoring; decision points defined after completion."
    },
    "plan-2025-support-recovery": {
      "when_label": "After chemotherapy (TBD)",
      "title": "Support and functional recovery",
      "summary": "Structured supportive care and rehabilitation.",
      "details": "Scope and schedule tailored to post‑chemo status and lab dynamics."
    },
    "plan-2025-tki-lifelong": {
      "when_label": "After stabilization (TBD)",
      "title": "Tyrosine kinase inhibitor (ponatinib) — long‑term",
      "summary": "Maintenance TKI after cytoreduction; likely long‑term/lifelong.",
      "details": "Start after acceptable hematologic control; monitor response and AEs; dose titration expected."
    },
    "plan-2025-re-irradiation": {
      "when_label": "If indicated (TBD)",
      "title": "Possible re‑irradiation",
      "summary": "Option if local control is needed.",
      "details": "To be discussed at tumor board; depends on imaging and prior RT doses."
    },
    "plan-2025-chemo-switch": {
      "when_label": "If current regimen proves insufficient (TBD)",
      "title": "Possible switch of current chemotherapy protocol",
      "summary": "Switch if response is inadequate or toxicity unacceptable.",
      "details": "Decision after reassessment of labs, imaging and tolerability; an alternative protocol chosen if indicated."
    },
    "plan-2025-next-line-chemo": {
      "when_label": "If needed (TBD)",
      "title": "Possible additional line of chemotherapy",
      "summary": "Option depending on disease dynamics.",
      "details": "To be determined by tumor board after evaluation of the current course."
    },
    "plan-2026-repeat-allo-sct": {
      "when_label": "2026 (possible)",
      "title": "Possible repeat allogeneic stem cell transplantation",
      "summary": "Option for definitive consolidation if required.",
      "details": "Depends on response to TKI and chemotherapy; would require donor/center evaluation and risk‑benefit analysis."
    }
  }
}
